+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Artificial Organs Market - Global Forecast 2026-2032- Product Image
Artificial Organs Market - Global Forecast 2026-2032- Product Image
Sale

Artificial Organs Market - Global Forecast 2026-2032

  • Report

  • 192 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6013919
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Artificial Organs Market is projected to reach USD 35.84 Billion in 2026. It is expected to continue growing at a CAGR of 9.26%, reaching USD 61.28 Billion by 2032.

Artificial Organs: Executive Summary and Strategic Context

Artificial organs encompass engineered or manufactured devices that replace, support, or replicate the function of biological organs. The field spans implantable systems, extracorporeal support technologies, tissue-engineered constructs, and emerging biohybrid approaches. Progress depends on the interaction of biomedical engineering, materials science, cell biology, surgery, manufacturing, and regulatory science. Clinical priorities include restoring function, improving patient safety, reducing complications, and expanding access to suitable treatment options.

How Biomaterials, Tissue Engineering, and Regulation Are Reshaping the Field

The landscape is shifting from purely mechanical replacement toward integrated systems that combine biomaterials, living cells, sensing, and adaptive control. Improvements in biocompatibility, surface engineering, miniaturization, additive manufacturing, and preservation methods are supporting more personalized designs and less invasive procedures. At the same time, developers face demanding evidence requirements involving durability, immune response, infection risk, cybersecurity, human factors, and long-term clinical performance. Scalable manufacturing and consistent quality systems remain essential as technologies move from specialized care into broader clinical use.

Artificial Intelligence Strengthens Design, Monitoring, and Clinical Decision Support

Artificial intelligence can contribute across the artificial-organ lifecycle by analyzing imaging and physiological data, supporting patient-device matching, optimizing designs, detecting early signs of failure, and informing maintenance or intervention decisions. Machine-learning systems may also help interpret complex biosignals and improve control of adaptive devices. However, reliable deployment requires representative datasets, transparent validation, robust cybersecurity, clinician oversight, and continuous monitoring for performance drift. AI should complement-not replace-clinical judgment, informed consent, and established safety controls.

Regional Insights: Infrastructure, Regulation, and Access Shape Adoption

North America is characterized by advanced clinical infrastructure, specialized research centers, and established pathways for high-risk medical technologies. Europe combines strong academic and industrial capabilities with coordinated regulatory and health-technology assessment considerations. Asia-Pacific includes major manufacturing, research, and hospital ecosystems, alongside substantial variation in reimbursement and access. Latin America is shaped by uneven specialist capacity, imported technology dependence, and opportunities for regional partnerships. The Middle East is investing in advanced healthcare infrastructure and precision medicine, while procurement, workforce development, and long-term support remain important. Africa faces pronounced differences in surgical capacity, diagnostics, financing, and maintenance infrastructure, making adaptable technologies and local capability building especially relevant.

Group Insights: Collaboration Networks Influence Standards and Deployment

ASEAN countries present a mix of advanced medical hubs and developing healthcare systems, creating opportunities for coordinated training, procurement, and regulatory cooperation. BRICS members bring significant scientific, industrial, and clinical diversity, but differences in standards, reimbursement, and technology access affect collaboration. The European Union benefits from cross-border research and regulatory coordination while continuing to address evidence generation and healthcare-system integration. G7 economies contribute substantial biomedical research, clinical expertise, and policy development. GCC countries are strengthening specialized healthcare capacity and may use centralized programs to support advanced therapies. NATO members, through overlapping national and alliance-level resilience priorities, have an interest in dependable medical supply chains, trauma care, and secure digital health infrastructure.

Country Insights: National Capabilities and Health-System Conditions Differ

Australia combines strong university research with geographically dispersed care requirements. Brazil has substantial clinical expertise and manufacturing potential, alongside regional disparities in access. Canada offers advanced research and public healthcare capacity, with geography influencing specialized-care delivery. China has extensive biomedical engineering activity and a large clinical base. France, Germany, Italy, and Spain contribute established research, manufacturing, and hospital systems, while each faces distinct reimbursement and implementation considerations. India combines a large clinical need with growing engineering and healthcare innovation capabilities. Japan is recognized for precision manufacturing, aging-population needs, and advanced medical research. Mexico is developing specialized capacity while managing access variation across regions. Russia maintains scientific and clinical capabilities but faces constraints related to supply chains and international collaboration. South Korea combines advanced electronics, manufacturing, and hospital infrastructure. The United Kingdom has strong translational research and regulatory expertise. The United States maintains broad capabilities across research, venture development, specialized surgery, and clinical implementation, with access shaped by complex payment and delivery structures.

Priorities for Leaders: Build Evidence, Resilience, and Patient-Centered Capability

Industry leaders should prioritize clinically meaningful outcomes, transparent evidence plans, and early engagement with regulators, hospitals, payers, and patients. Product development should incorporate biocompatibility, cybersecurity, usability, explant or revision planning, and lifecycle support from the outset. Partnerships with specialist centers can strengthen validation, while modular manufacturing and diversified suppliers can improve resilience. Leaders should also invest in clinician training, service networks, post-market surveillance, and equitable access models. AI-enabled functions warrant documented governance, bias testing, explainability appropriate to risk, and clear accountability for human oversight.

Research Methodology: Evidence-Based Synthesis of the Artificial-Organ Landscape

This executive summary uses a structured qualitative synthesis of the artificial-organs field. The approach considers technology categories, clinical applications, enabling sciences, regulatory requirements, healthcare infrastructure, manufacturing conditions, and regional implementation factors. Insights are framed around observable developments in engineering, translational research, clinical practice, policy, and access rather than unsupported numerical claims. Regional, group, and country narratives reflect differences in research capacity, health-system organization, specialist availability, industrial ecosystems, and adoption conditions. Claims should be validated against current peer-reviewed literature, regulatory publications, clinical-trial records, standards, and national health-system documentation before investment or policy decisions.

Conclusion: Responsible Integration Will Determine Long-Term Clinical Value

Artificial organs are advancing through convergence among engineering, biology, digital technologies, and clinical practice. The strongest opportunities are likely to emerge where technical performance is matched by durable clinical evidence, reliable manufacturing, skilled care teams, and sustainable patient support. Artificial intelligence can improve personalization and monitoring, but its value depends on trustworthy data and accountable governance. Progress across North America, Latin America, Europe, the Middle East, Africa, and Asia-Pacific will therefore depend not only on invention, but also on regulation, infrastructure, affordability, workforce development, and equitable implementation.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Artificial Organs Market, by Organ Type
7.1. Introduction
7.2. Heart
7.3. Kidney
7.4. Liver
7.5. Lung
7.6. Pancreas
8. Artificial Organs Market, by Product Type
8.1. Introduction
8.2. Bioartificial
8.2.1. Bioartificial Kidney
8.2.1.1. Filtration-Based Systems
8.2.1.2. Hybrid Functional Units
8.2.2. Bioartificial Liver
8.2.2.1. Hepatocyte-Based Systems
8.2.2.2. Scaffold-Based Units
8.3. Mechanical
8.3.1. Dialysis Machine
8.3.1.1. Hemodialysis
8.3.1.2. Peritoneal Dialysis
8.3.2. Extracorporeal Membrane Oxygenation
8.3.2.1. VA-ECMO
8.3.2.2. VV-ECMO
8.3.3. Ventricular Assist Device
8.3.3.1. Left Ventricular Assist Device
8.3.3.2. Right Ventricular Assist Device
8.4. Tissue Engineered
8.4.1. Cell-Based Therapies
8.4.1.1. Primary Cell Therapies
8.4.1.2. Stem Cell Therapies
8.4.2. Scaffold-Based Constructs
8.4.2.1. Decellularized Scaffolds
8.4.2.2. Functionalized Scaffolds
9. Artificial Organs Market, by Technology
9.1. Introduction
9.2. 3D Bioprinting
9.2.1. Extrusion-Based
9.2.2. Inkjet-Based
9.2.3. Laser-Assisted
9.3. Decellularization
9.4. Microfluidics
9.5. Scaffold Technology
9.6. Wearable Devices
10. Artificial Organs Market, by End User
10.1. Introduction
10.2. Ambulatory Care Centers
10.2.1. Clinics
10.2.2. Day Surgery Centers
10.3. Hospitals
10.3.1. Private Hospitals
10.3.2. Public Hospitals
10.4. Research Institutes
10.5. Specialty Clinics
11. Artificial Organs Market, by Distribution Channel
11.1. Introduction
11.2. Direct Sales
11.3. Distributors
11.4. Hospital Procurement
11.5. Online Platforms
12. Artificial Organs Market, by Region
12.1. Introduction
12.2. Asia-Pacific
12.3. North America
12.4. Latin America
12.5. Europe
12.6. Middle East
12.7. Africa
13. Artificial Organs Market, by Group
13.1. Introduction
13.2. ASEAN
13.3. GCC
13.4. European Union
13.5. BRICS
13.6. G7
13.7. NATO
14. Artificial Organs Market, by Country
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. United Kingdom
14.7. Germany
14.8. France
14.9. Russia
14.10. Italy
14.11. Spain
14.12. China
14.13. India
14.14. Japan
14.15. Australia
14.16. South Korea
15. Competitive Landscape
15.1. Market Share Analysis, 2025
15.2. Market Concentration Analysis, 2025
15.2.1. Concentration Ratio (CR)
15.2.2. Herfindahl Hirschman Index (HHI)
15.3. Recent Developments & Impact Analysis, 2025
15.4. Product Portfolio Analysis, 2025
15.5. Benchmarking Analysis, 2025
16. Company Profiles
16.1. Alt-Bionics, LLC
16.2. Axiles Bionics
16.3. Baxter International Inc.
16.4. Berlin Heart GmbH
16.5. Beta Bionics, Inc.
16.6. Bionic India
16.7. Boston Scientific Corporation
16.8. Carmat SA
16.9. COVVI Ltd.
16.10. Ekso Bionics Holdings, Inc.
16.11. German Bionic Systems GmbH
16.12. iWALKFree, Inc.
16.13. Jarvik Heart, Inc.
16.14. Medtronic Plc
16.15. Nipro Corporation
16.16. Open Bionics Ltd.
16.17. Pixium Vision SA
16.18. ReWalk Robotics Ltd.
16.19. Sonova AG
16.20. SynCardia Systems, LLC
16.21. Vivani Medical, Inc.
16.22. Zimmer Biomet Holdings, Inc.
16.23. Össur hf.
17. Key Experts
LIST OF FIGURES
FIGURE 1. Global Artificial Organs Market, Years Considered for the Study
FIGURE 2. Global Artificial Organs Market, Research Design
FIGURE 3. Global Artificial Organs Market, Research Framework
FIGURE 4. Global Artificial Organs Market, Data Triangulation
FIGURE 5. Global Artificial Organs Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Artificial Organs Market Size, by Organ Type, 2025 vs 2032 (%)
FIGURE 7. Global Artificial Organs Market Size, by Organ Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Artificial Organs Market Size, by Product Type, 2025 vs 2032 (%)
FIGURE 9. Global Artificial Organs Market Size, by Product Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Artificial Organs Market Size, by Technology, 2025 vs 2032 (%)
FIGURE 11. Global Artificial Organs Market Size, by Technology, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Artificial Organs Market Size, by End User, 2025 vs 2032 (%)
FIGURE 13. Global Artificial Organs Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Artificial Organs Market Size, by Distribution Channel, 2025 vs 2032 (%)
FIGURE 15. Global Artificial Organs Market Size, by Distribution Channel, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Artificial Organs Market Size, by Region, 2025 vs 2032 (%)
FIGURE 17. Global Artificial Organs Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global Artificial Organs Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global Artificial Organs Market Size, by Country, 2025 vs 2032 (%)
FIGURE 20. Global Artificial Organs Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 21. Global Artificial Organs Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Artificial Organs Market Segmentation & Coverage
TABLE 2. Global Artificial Organs Market Size, 2017-2032 (USD Million)
TABLE 3. Global Artificial Organs Market Size, by Organ Type, 2017-2032 (USD Million)
TABLE 4. Global Heart Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Heart Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Heart Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Kidney Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Kidney Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Kidney Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Liver Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Liver Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Liver Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Lung Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Lung Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Lung Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Pancreas Market Size, by Region, 2017-2032 (USD Million)
TABLE 17. Global Pancreas Market Size, by Group, 2017-2032 (USD Million)
TABLE 18. Global Pancreas Market Size, by Country, 2017-2032 (USD Million)
TABLE 19. Global Artificial Organs Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 20. Global Bioartificial Market Size, by Region, 2017-2032 (USD Million)
TABLE 21. Global Bioartificial Market Size, by Group, 2017-2032 (USD Million)
TABLE 22. Global Bioartificial Market Size, by Country, 2017-2032 (USD Million)
TABLE 23. Global Bioartificial Kidney Market Size, by Region, 2017-2032 (USD Million)
TABLE 24. Global Bioartificial Kidney Market Size, by Group, 2017-2032 (USD Million)
TABLE 25. Global Bioartificial Kidney Market Size, by Country, 2017-2032 (USD Million)
TABLE 26. Global Filtration-Based Systems Market Size, by Region, 2017-2032 (USD Million)
TABLE 27. Global Filtration-Based Systems Market Size, by Group, 2017-2032 (USD Million)
TABLE 28. Global Filtration-Based Systems Market Size, by Country, 2017-2032 (USD Million)
TABLE 29. Global Hybrid Functional Units Market Size, by Region, 2017-2032 (USD Million)
TABLE 30. Global Hybrid Functional Units Market Size, by Group, 2017-2032 (USD Million)
TABLE 31. Global Hybrid Functional Units Market Size, by Country, 2017-2032 (USD Million)
TABLE 32. Global Bioartificial Liver Market Size, by Region, 2017-2032 (USD Million)
TABLE 33. Global Bioartificial Liver Market Size, by Group, 2017-2032 (USD Million)
TABLE 34. Global Bioartificial Liver Market Size, by Country, 2017-2032 (USD Million)
TABLE 35. Global Hepatocyte-Based Systems Market Size, by Region, 2017-2032 (USD Million)
TABLE 36. Global Hepatocyte-Based Systems Market Size, by Group, 2017-2032 (USD Million)
TABLE 37. Global Hepatocyte-Based Systems Market Size, by Country, 2017-2032 (USD Million)
TABLE 38. Global Scaffold-Based Units Market Size, by Region, 2017-2032 (USD Million)
TABLE 39. Global Scaffold-Based Units Market Size, by Group, 2017-2032 (USD Million)
TABLE 40. Global Scaffold-Based Units Market Size, by Country, 2017-2032 (USD Million)
TABLE 41. Global Mechanical Market Size, by Region, 2017-2032 (USD Million)
TABLE 42. Global Mechanical Market Size, by Group, 2017-2032 (USD Million)
TABLE 43. Global Mechanical Market Size, by Country, 2017-2032 (USD Million)
TABLE 44. Global Dialysis Machine Market Size, by Region, 2017-2032 (USD Million)
TABLE 45. Global Dialysis Machine Market Size, by Group, 2017-2032 (USD Million)
TABLE 46. Global Dialysis Machine Market Size, by Country, 2017-2032 (USD Million)
TABLE 47. Global Hemodialysis Market Size, by Region, 2017-2032 (USD Million)
TABLE 48. Global Hemodialysis Market Size, by Group, 2017-2032 (USD Million)
TABLE 49. Global Hemodialysis Market Size, by Country, 2017-2032 (USD Million)
TABLE 50. Global Peritoneal Dialysis Market Size, by Region, 2017-2032 (USD Million)
TABLE 51. Global Peritoneal Dialysis Market Size, by Group, 2017-2032 (USD Million)
TABLE 52. Global Peritoneal Dialysis Market Size, by Country, 2017-2032 (USD Million)
TABLE 53. Global Extracorporeal Membrane Oxygenation Market Size, by Region, 2017-2032 (USD Million)
TABLE 54. Global Extracorporeal Membrane Oxygenation Market Size, by Group, 2017-2032 (USD Million)
TABLE 55. Global Extracorporeal Membrane Oxygenation Market Size, by Country, 2017-2032 (USD Million)
TABLE 56. Global VA-ECMO Market Size, by Region, 2017-2032 (USD Million)
TABLE 57. Global VA-ECMO Market Size, by Group, 2017-2032 (USD Million)
TABLE 58. Global VA-ECMO Market Size, by Country, 2017-2032 (USD Million)
TABLE 59. Global VV-ECMO Market Size, by Region, 2017-2032 (USD Million)
TABLE 60. Global VV-ECMO Market Size, by Group, 2017-2032 (USD Million)
TABLE 61. Global VV-ECMO Market Size, by Country, 2017-2032 (USD Million)
TABLE 62. Global Ventricular Assist Device Market Size, by Region, 2017-2032 (USD Million)
TABLE 63. Global Ventricular Assist Device Market Size, by Group, 2017-2032 (USD Million)
TABLE 64. Global Ventricular Assist Device Market Size, by Country, 2017-2032 (USD Million)
TABLE 65. Global Left Ventricular Assist Device Market Size, by Region, 2017-2032 (USD Million)
TABLE 66. Global Left Ventricular Assist Device Market Size, by Group, 2017-2032 (USD Million)
TABLE 67. Global Left Ventricular Assist Device Market Size, by Country, 2017-2032 (USD Million)
TABLE 68. Global Right Ventricular Assist Device Market Size, by Region, 2017-2032 (USD Million)
TABLE 69. Global Right Ventricular Assist Device Market Size, by Group, 2017-2032 (USD Million)
TABLE 70. Global Right Ventricular Assist Device Market Size, by Country, 2017-2032 (USD Million)
TABLE 71. Global Tissue Engineered Market Size, by Region, 2017-2032 (USD Million)
TABLE 72. Global Tissue Engineered Market Size, by Group, 2017-2032 (USD Million)
TABLE 73. Global Tissue Engineered Market Size, by Country, 2017-2032 (USD Million)
TABLE 74. Global Cell-Based Therapies Market Size, by Region, 2017-2032 (USD Million)
TABLE 75. Global Cell-Based Therapies Market Size, by Group, 2017-2032 (USD Million)
TABLE 76. Global Cell-Based Therapies Market Size, by Country, 2017-2032 (USD Million)
TABLE 77. Global Primary Cell Therapies Market Size, by Region, 2017-2032 (USD Million)
TABLE 78. Global Primary Cell Therapies Market Size, by Group, 2017-2032 (USD Million)
TABLE 79. Global Primary Cell Therapies Market Size, by Country, 2017-2032 (USD Million)
TABLE 80. Global Stem Cell Therapies Market Size, by Region, 2017-2032 (USD Million)
TABLE 81. Global Stem Cell Therapies Market Size, by Group, 2017-2032 (USD Million)
TABLE 82. Global Stem Cell Therapies Market Size, by Country, 2017-2032 (USD Million)
TABLE 83. Global Scaffold-Based Constructs Market Size, by Region, 2017-2032 (USD Million)
TABLE 84. Global Scaffold-Based Constructs Market Size, by Group, 2017-2032 (USD Million)
TABLE 85. Global Scaffold-Based Constructs Market Size, by Country, 2017-2032 (USD Million)
TABLE 86. Global Decellularized Scaffolds Market Size, by Region, 2017-2032 (USD Million)
TABLE 87. Global Decellularized Scaffolds Market Size, by Group, 2017-2032 (USD Million)
TABLE 88. Global Decellularized Scaffolds Market Size, by Country, 2017-2032 (USD Million)
TABLE 89. Global Functionalized Scaffolds Market Size, by Region, 2017-2032 (USD Million)
TABLE 90. Global Functionalized Scaffolds Market Size, by Group, 2017-2032 (USD Million)
TABLE 91. Global Functionalized Scaffolds Market Size, by Country, 2017-2032 (USD Million)
TABLE 92. Global Artificial Organs Market Size, by Technology, 2017-2032 (USD Million)
TABLE 93. Global 3D Bioprinting Market Size, by Region, 2017-2032 (USD Million)
TABLE 94. Global 3D Bioprinting Market Size, by Group, 2017-2032 (USD Million)
TABLE 95. Global 3D Bioprinting Market Size, by Country, 2017-2032 (USD Million)
TABLE 96. Global Extrusion-Based Market Size, by Region, 2017-2032 (USD Million)
TABLE 97. Global Extrusion-Based Market Size, by Group, 2017-2032 (USD Million)
TABLE 98. Global Extrusion-Based Market Size, by Country, 2017-2032 (USD Million)
TABLE 99. Global Inkjet-Based Market Size, by Region, 2017-2032 (USD Million)
TABLE 100. Global Inkjet-Based Market Size, by Group, 2017-2032 (USD Million)
TABLE 101. Global Inkjet-Based Market Size, by Country, 2017-2032 (USD Million)
TABLE 102. Global Laser-Assisted Market Size, by Region, 2017-2032 (USD Million)
TABLE 103. Global Laser-Assisted Market Size, by Group, 2017-2032 (USD Million)
TABLE 104. Global Laser-Assisted Market Size, by Country, 2017-2032 (USD Million)
TABLE 105. Global Decellularization Market Size, by Region, 2017-2032 (USD Million)
TABLE 106. Global Decellularization Market Size, by Group, 2017-2032 (USD Million)
TABLE 107. Global Decellularization Market Size, by Country, 2017-2032 (USD Million)
TABLE 108. Global Microfluidics Market Size, by Region, 2017-2032 (USD Million)
TABLE 109. Global Microfluidics Market Size, by Group, 2017-2032 (USD Million)
TABLE 110. Global Microfluidics Market Size, by Country, 2017-2032 (USD Million)
TABLE 111. Global Scaffold Technology Market Size, by Region, 2017-2032 (USD Million)
TABLE 112. Global Scaffold Technology Market Size, by Group, 2017-2032 (USD Million)
TABLE 113. Global Scaffold Technology Market Size, by Country, 2017-2032 (USD Million)
TABLE 114. Global Wearable Devices Market Size, by Region, 2017-2032 (USD Million)
TABLE 115. Global Wearable Devices Market Size, by Group, 2017-2032 (USD Million)
TABLE 116. Global Wearable Devices Market Size, by Country, 2017-2032 (USD Million)
TABLE 117. Global Artificial Organs Market Size, by End User, 2017-2032 (USD Million)
TABLE 118. Global Ambulatory Care Centers Market Size, by Region, 2017-2032 (USD Million)
TABLE 119. Global Ambulatory Care Centers Market Size, by Group, 2017-2032 (USD Million)
TABLE 120. Global Ambulatory Care Centers Market Size, by Country, 2017-2032 (USD Million)
TABLE 121. Global Clinics Market Size, by Region, 2017-2032 (USD Million)
TABLE 122. Global Clinics Market Size, by Group, 2017-2032 (USD Million)
TABLE 123. Global Clinics Market Size, by Country, 2017-2032 (USD Million)
TABLE 124. Global Day Surgery Centers Market Size, by Region, 2017-2032 (USD Million)
TABLE 125. Global Day Surgery Centers Market Size, by Group, 2017-2032 (USD Million)
TABLE 126. Global Day Surgery Centers Market Size, by Country, 2017-2032 (USD Million)
TABLE 127. Global Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 128. Global Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 129. Global Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 130. Global Private Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 131. Global Private Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 132. Global Private Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 133. Global Public Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 134. Global Public Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 135. Global Public Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 136. Global Research Institutes Market Size, by Region, 2017-2032 (USD Million)
TABLE 137. Global Research Institutes Market Size, by Group, 2017-2032 (USD Million)
TABLE 138. Global Research Institutes Market Size, by Country, 2017-2032 (USD Million)
TABLE 139. Global Specialty Clinics Market Size, by Region, 2017-2032 (USD Million)
TABLE 140. Global Specialty Clinics Market Size, by Group, 2017-2032 (USD Million)
TABLE 141. Global Specialty Clinics Market Size, by Country, 2017-2032 (USD Million)
TABLE 142. Global Artificial Organs Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 143. Global Direct Sales Market Size, by Region, 2017-2032 (USD Million)
TABLE 144. Global Direct Sales Market Size, by Group, 2017-2032 (USD Million)
TABLE 145. Global Direct Sales Market Size, by Country, 2017-2032 (USD Million)
TABLE 146. Global Distributors Market Size, by Region, 2017-2032 (USD Million)
TABLE 147. Global Distributors Market Size, by Group, 2017-2032 (USD Million)
TABLE 148. Global Distributors Market Size, by Country, 2017-2032 (USD Million)
TABLE 149. Global Hospital Procurement Market Size, by Region, 2017-2032 (USD Million)
TABLE 150. Global Hospital Procurement Market Size, by Group, 2017-2032 (USD Million)
TABLE 151. Global Hospital Procurement Market Size, by Country, 2017-2032 (USD Million)
TABLE 152. Global Online Platforms Market Size, by Region, 2017-2032 (USD Million)
TABLE 153. Global Online Platforms Market Size, by Group, 2017-2032 (USD Million)
TABLE 154. Global Online Platforms Market Size, by Country, 2017-2032 (USD Million)
TABLE 155. Global Artificial Organs Market Size, by Region, 2017-2032 (USD Million)
TABLE 156. Asia-Pacific Artificial Organs Market Size, by Region, 2017-2032 (USD Million)
TABLE 157. Asia-Pacific Artificial Organs Market Size, by Organ Type, 2017-2032 (USD Million)
TABLE 158. Asia-Pacific Artificial Organs Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 159. Asia-Pacific Artificial Organs Market Size, by Bioartificial, 2017-2032 (USD Million)
TABLE 160. Asia-Pacific Artificial Organs Market Size, by Bioartificial Kidney, 2017-2032 (USD Million)
TABLE 161. Asia-Pacific Artificial Organs Market Size, by Bioartificial Liver, 2017-2032 (USD Million)
TABLE 162. Asia-Pacific Artificial Organs Market Size, by Mechanical, 2017-2032 (USD Million)
TABLE 163. Asia-Pacific Artificial Organs Market Size, by Dialysis Machine, 2017-2032 (USD Million)
TABLE 164. Asia-Pacific Artificial Organs Market Size, by Extracorporeal Membrane Oxygenation, 2017-2032 (USD Million)
TABLE 165. Asia-Pacific Artificial Organs Market Size, by Ventricular Assist Device, 2017-2032 (USD Million)
TABLE 166. Asia-Pacific Artificial Organs Market Size, by Tissue Engineered, 2017-2032 (USD Million)
TABLE 167. Asia-Pacific Artificial Organs Market Size, by Cell-Based Therapies, 2017-2032 (USD Million)
TABLE 168. Asia-Pacific Artificial Organs Market Size, by Scaffold-Based Constructs, 2017-2032 (USD Million)
TABLE 169. Asia-Pacific Artificial Organs Market Size, by Technology, 2017-2032 (USD Million)
TABLE 170. Asia-Pacific Artificial Organs Market Size, by 3D Bioprinting, 2017-2032 (USD Million)
TABLE 171. Asia-Pacific Artificial Organs Market Size, by End User, 2017-2032 (USD Million)
TABLE 172. Asia-Pacific Artificial Organs Market Size, by Ambulatory Care Centers, 2017-2032 (USD Million)
TABLE 173. Asia-Pacific Artificial Organs Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 174. Asia-Pacific Artificial Organs Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 175. North America Artificial Organs Market Size, by Region, 2017-2032 (USD Million)
TABLE 176. North America Artificial Organs Market Size, by Organ Type, 2017-2032 (USD Million)
TABLE 177. North America Artificial Organs Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 178. North America Artificial Organs Market Size, by Bioartificial, 2017-2032 (USD Million)
TABLE 179. North America Artificial Organs Market Size, by Bioartificial Kidney, 2017-2032 (USD Million)
TABLE 180. North America Artificial Organs Market Size, by Bioartificial Liver, 2017-2032 (USD Million)
TABLE 181. North America Artificial Organs Market Size, by Mechanical, 2017-2032 (USD Million)
TABLE 182. North America Artificial Organs Market Size, by Dialysis Machine, 2017-2032 (USD Million)
TABLE 183. North America Artificial Organs Market Size, by Extracorporeal Membrane Oxygenation, 2017-2032 (USD Million)
TABLE 184. North America Artificial Organs Market Size, by Ventricular Assist Device, 2017-2032 (USD Million)
TABLE 185. North America Artificial Organs Market Size, by Tissue Engineered, 2017-2032 (USD Million)
TABLE 186. North America Artificial Organs Market Size, by Cell-Based Therapies, 2017-2032 (USD Million)
TABLE 187. North America Artificial Organs Market Size, by Scaffold-Based Constructs, 2017-2032 (USD Million)
TABLE 188. North America Artificial Organs Market Size, by Technology, 2017-2032 (USD Million)
TABLE 189. North America Artificial Organs Market Size, by 3D Bioprinting, 2017-2032 (USD Million)
TABLE 190. North America Artificial Organs Market Size, by End User, 2017-2032 (USD Million)
TABLE 191. North America Artificial Organs Market Size, by Ambulatory Care Centers, 2017-2032 (USD Million)
TABLE 192. North America Artificial Organs Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 193. North America Artificial Organs Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 194. Latin America Artificial Organs Market Size, by Region, 2017-2032 (USD Million)
TABLE 195. Latin America Artificial Organs Market Size, by Organ Type, 2017-2032 (USD Million)
TABLE 196. Latin America Artificial Organs Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 197. Latin America Artificial Organs Market Size, by Bioartificial, 2017-2032 (USD Million)
TABLE 198. Latin America Artificial Organs Market Size, by Bioartificial Kidney, 2017-2032 (USD Million)
TABLE 199. Latin America Artificial Organs Market Size, by Bioartificial Liver, 2017-2032 (USD Million)
TABLE 200. Latin America Artificial Organs Market Size, by Mechanical, 2017-2032 (USD Million)
TABLE 201. Latin America Artificial Organs Market Size, by Dialysis Machine, 2017-2032 (USD Million)
TABLE 202. Latin America Artificial Organs Market Size, by Extracorporeal Membrane Oxygenation, 2017-2032 (USD Million)
TABLE 203. Latin America Artificial Organs Market Size, by Ventricular Assist Device, 2017-2032 (USD Million)
TABLE 204. Latin America Artificial Organs Market Size, by Tissue Engineered, 2017-2032 (USD Million)
TABLE 205. Latin America Artificial Organs Market Size, by Cell-Based Therapies, 2017-2032 (USD Million)
TABLE 206. Latin America Artificial Organs Market Size, by Scaffold-Based Constructs, 2017-2032 (USD Million)
TABLE 207. Latin America Artificial Organs Market Size, by Technology, 2017-2032 (USD Million)
TABLE 208. Latin America Artificial Organs Market Size, by 3D Bioprinting, 2017-2032 (USD Million)
TABLE 209. Latin America Artificial Organs Market Size, by End User, 2017-2032 (USD Million)
TABLE 210. Latin America Artificial Organs Market Size, by Ambulatory Care Centers, 2017-2032 (USD Million)
TABLE 211. Latin America Artificial Organs Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 212. Latin America Artificial Organs Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 213. Europe Artificial Organs Market Size, by Region, 2017-2032 (USD Million)
TABLE 214. Europe Artificial Organs Market Size, by Organ Type, 2017-2032 (USD Million)
TABLE 215. Europe Artificial Organs Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 216. Europe Artificial Organs Market Size, by Bioartificial, 2017-2032 (USD Million)
TABLE 217. Europe Artificial Organs Market Size, by Bioartificial Kidney, 2017-2032 (USD Million)
TABLE 218. Europe Artificial Organs Market Size, by Bioartificial Liver, 2017-2032 (USD Million)
TABLE 219. Europe Artificial Organs Market Size, by Mechanical, 2017-2032 (USD Million)
TABLE 220. Europe Artificial Organs Market Size, by Dialysis Machine, 2017-2032 (USD Million)
TABLE 221. Europe Artificial Organs Market Size, by Extracorporeal Membrane Oxygenation, 2017-2032 (USD Million)
TABLE 222. Europe Artificial Organs Market Size, by Ventricular Assist Device, 2017-2032 (USD Million)
TABLE 223. Europe Artificial Organs Market Size, by Tissue Engineered, 2017-2032 (USD Million)
TABLE 224. Europe Artificial Organs Market Size, by Cell-Based Therapies, 2017-2032 (USD Million)
TABLE 225. Europe Artificial Organs Market Size, by Scaffold-Based Constructs, 2017-2032 (USD Million)
TABLE 226. Europe Artificial Organs Market Size, by Technology, 2017-2032 (USD Million)
TABLE 227. Europe Artificial Organs Market Size, by 3D Bioprinting, 2017-2032 (USD Million)
TABLE 228. Europe Artificial Organs Market Size, by End User, 2017-2032 (USD Million)
TABLE 229. Europe Artificial Organs Market Size, by Ambulatory Care Centers, 2017-2032 (USD Million)
TABLE 230. Europe Artificial Organs Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 231. Europe Artificial Organs Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 232. Middle East Artificial Organs Market Size, by Region, 2017-2032 (USD Million)
TABLE 233. Middle East Artificial Organs Market Size, by Organ Type, 2017-2032 (USD Million)
TABLE 234. Middle East Artificial Organs Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 235. Middle East Artificial Organs Market Size, by Bioartificial, 2017-2032 (USD Million)
TABLE 236. Middle East Artificial Organs Market Size, by Bioartificial Kidney, 2017-2032 (USD Million)
TABLE 237. Middle East Artificial Organs Market Size, by Bioartificial Liver, 2017-2032 (USD Million)
TABLE 238. Middle East Artificial Organs Market Size, by Mechanical, 2017-2032 (USD Million)
TABLE 239. Middle East Artificial Organs Market Size, by Dialysis Machine, 2017-2032 (USD Million)
TABLE 240. Middle East Artificial Organs Market Size, by Extracorporeal Membrane Oxygenation, 2017-2032 (USD Million)
TABLE 241. Middle East Artificial Organs Market Size, by Ventricular Assist Device, 2017-2032 (USD Million)
TABLE 242. Middle East Artificial Organs Market Size, by Tissue Engineered, 2017-2032 (USD Million)
TABLE 243. Middle East Artificial Organs Market Size, by Cell-Based Therapies, 2017-2032 (USD Million)
TABLE 244. Middle East Artificial Organs Market Size, by Scaffold-Based Constructs, 2017-2032 (USD Million)
TABLE 245. Middle East Artificial Organs Market Size, by Technology, 2017-2032 (USD Million)
TABLE 246. Middle East Artificial Organs Market Size, by 3D Bioprinting, 2017-2032 (USD Million)
TABLE 247. Middle East Artificial Organs Market Size, by End User, 2017-2032 (USD Million)
TABLE 248. Middle East Artificial Organs Market Size, by Ambulatory Care Centers, 2017-2032 (USD Million)
TABLE 249. Middle East Artificial Organs Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 250. Middle East Artificial Organs Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 251. Africa Artificial Organs Market Size, by Region, 2017-2032 (USD Million)
TABLE 252. Africa Artificial Organs Market Size, by Organ Type, 2017-2032 (USD Million)
TABLE 253. Africa Artificial Organs Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 254. Africa Artificial Organs Market Size, by Bioartificial, 2017-2032 (USD Million)
TABLE 255. Africa Artificial Organs Market Size, by Bioartificial Kidney, 2017-2032 (USD Million)
TABLE 256. Africa Artificial Organs Market Size, by Bioartificial Liver, 2017-2032 (USD Million)
TABLE 257. Africa Artificial Organs Market Size, by Mechanical, 2017-2032 (USD Million)
TABLE 258. Africa Artificial Organs Market Size, by Dialysis Machine, 2017-2032 (USD Million)
TABLE 259. Africa Artificial Organs Market Size, by Extracorporeal Membrane Oxygenation, 2017-2032 (USD Million)
TABLE 260. Africa Artificial Organs Market Size, by Ventricular Assist Device, 2017-2032 (USD Million)
TABLE 261. Africa Artificial Organs Market Size, by Tissue Engineered, 2017-2032 (USD Million)
TABLE 262. Africa Artificial Organs Market Size, by Cell-Based Therapies, 2017-2032 (USD Million)
TABLE 263. Africa Artificial Organs Market Size, by Scaffold-Based Constructs, 2017-2032 (USD Million)
TABLE 264. Africa Artificial Organs Market Size, by Technology, 2017-2032 (USD Million)
TABLE 265. Africa Artificial Organs Market Size, by 3D Bioprinting, 2017-2032 (USD Million)
TABLE 266. Africa Artificial Organs Market Size, by End User, 2017-2032 (USD Million)
TABLE 267. Africa Artificial Organs Market Size, by Ambulatory Care Centers, 2017-2032 (USD Million)
TABLE 268. Africa Artificial Organs Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 269. Africa Artificial Organs Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 270. Global Artificial Organs Market Size, by Group, 2017-2032 (USD Million)
TABLE 271. ASEAN Artificial Organs Market Size, by Group, 2017-2032 (USD Million)
TABLE 272. ASEAN Artificial Organs Market Size, by Organ Type, 2017-2032 (USD Million)
TABLE 273. ASEAN Artificial Organs Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 274. ASEAN Artificial Organs Market Size, by Bioartificial, 2017-2032 (USD Million)
TABLE 275. ASEAN Artificial Organs Market Size, by Bioartificial Kidney, 2017-2032 (USD Million)
TABLE 276. ASEAN Artificial Organs Market Size, by Bioartificial Liver, 2017-2032 (USD Million)
TABLE 277. ASEAN Artificial Organs Market Size, by Mechanical, 2017-2032 (USD Million)
TABLE 278. ASEAN Artificial Organs Market Size, by Dialysis Machine, 2017-2032 (USD Million)
TABLE 279. ASEAN Artificial Organs Market Size, by Extracorporeal Membrane Oxygenation, 2017-2032 (USD Million)
TABLE 280. ASEAN Artificial Organs Market Size, by Ventricular Assist Device, 2017-2032 (USD Million)
TABLE 281. ASEAN Artificial Organs Market Size, by Tissue Engineered, 2017-2032 (USD Million)
TABLE 282. ASEAN Artificial Organs Market Size, by Cell-Based Therapies, 2017-2032 (USD Million)
TABLE 283. ASEAN Artificial Organs Market Size, by Scaffold-Based Constructs, 2017-2032 (USD Million)
TABLE 284. ASEAN Artificial Organs Market Size, by Technology, 2017-2032 (USD Million)
TABLE 285. ASEAN Artificial Organs Market Size, by 3D Bioprinting, 2017-2032 (USD Million)
TABLE 286. ASEAN Artificial Organs Market Size, by End User, 2017-2032 (USD Million)
TABLE 287. ASEAN Artificial Organs Market Size, by Ambulatory Care Centers, 2017-2032 (USD Million)
TABLE 288. ASEAN Artificial Organs Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 289. ASEAN Artificial Organs Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 290. GCC Artificial Organs Market Size, by Group, 2017-2032 (USD Million)
TABLE 291. GCC Artificial Organs Market Size, by Organ Type, 2017-2032 (USD Million)
TABLE 292. GCC Artificial Organs Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 293. GCC Artificial Organs Market Size, by Bioartificial, 2017-2032 (USD Million)
TABLE 294. GCC Artificial Organs Market Size, by Bioartificial Kidney, 2017-2032 (USD Million)
TABLE 295. GCC Artificial Organs Market Size, by Bioartificial Liver, 2017-2032 (USD Million)
TABLE 296. GCC Artificial Organs Market Size, by Mechanical, 2017-2032 (USD Million)
TABLE 297. GCC Artificial Organs Market Size, by Dialysis Machine, 2017-2032 (USD Million)
TABLE 298. GCC Artificial Organs Market Size, by Extracorporeal Membrane Oxygenation, 2017-2032 (USD Million)
TABLE 299. GCC Artificial Organs Market Size, by Ventricular Assist Device, 2017-2032 (USD Million)
TABLE 300. GCC Artificial Organs Market Size, by Tissue Engineered, 2017-2032 (USD Million)
TABLE 301. GCC Artificial Organs Market Size, by Cell-Based Therapies, 2017-2032 (USD Million)
TABLE 302. GCC Artificial Organs Market Size, by Scaffold-Based Constructs, 2017-2032 (USD Million)
TABLE 303. GCC Artificial Organs Market Size, by Technology, 2017-2032 (USD Million)
TABLE 304. GCC Artificial Organs Market Size, by 3D Bioprinting, 2017-2032 (USD Million)
TABLE 305. GCC Artificial Organs Market Size, by End User, 2017-2032 (USD Million)
TABLE 306. GCC Artificial Organs Market Size, by Ambulatory Care Centers, 2017-2032 (USD Million)
TABLE 307. GCC Artificial Organs Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 308. GCC Artificial Organs Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 309. European Union Artificial Organs Market Size, by Group, 2017-2032 (USD Million)
TABLE 310. European Union Artificial Organs Market Size, by Organ Type, 2017-2032 (USD Million)
TABLE 311. European Union Artificial Organs Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 312. European Union Artificial Organs Market Size, by Bioartificial, 2017-2032 (USD Million)
TABLE 313. European Union Artificial Organs Market Size, by Bioartificial Kidney, 2017-2032 (USD Million)
TABLE 314. European Union Artificial Organs Market Size, by Bioartificial Liver, 2017-2032 (USD Million)
TABLE 315. European Union Artificial Organs Market Size, by Mechanical, 2017-2032 (USD Million)
TABLE 316. European Union Artificial Organs Market Size, by Dialysis Machine, 2017-2032 (USD Million)
TABLE 317. European Union Artificial Organs Market Size, by Extracorporeal Membrane Oxygenation, 2017-2032 (USD Million)
TABLE 318. European Union Artificial Organs Market Size, by Ventricular Assist Device, 2017-2032 (USD Million)
TABLE 319. European Union Artificial Organs Market Size, by Tissue Engineered, 2017-2032 (USD Million)
TABLE 320. European Union Artificial Organs Market Size, by Cell-Based Therapies, 2017-2032 (USD Million)
TABLE 321. European Union Artificial Organs Market Size, by Scaffold-Based Constructs, 2017-2032 (USD Million)
TABLE 322. European Union Artificial Organs Market Size, by Technology, 2017-2032 (USD Million)
TABLE 323. European Union Artificial Organs Market Size, by 3D Bioprinting, 2017-2032 (USD Million)
TABLE 324. European Union Artificial Organs Market Size, by End User, 2017-2032 (USD Million)
TABLE 325. European Union Artificial Organs Market Size, by Ambulatory Care Centers, 2017-2032 (USD Million)
TABLE 326. European Union Artificial Organs Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 327. European Union Artificial Organs Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 328. BRICS Artificial Organs Market Size, by Group, 2017-2032 (USD Million)
TABLE 329. BRICS Artificial Organs Market Size, by Organ Type, 2017-2032 (USD Million)
TABLE 330. BRICS Artificial Organs Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 331. BRICS Artificial Organs Market Size, by Bioartificial, 2017-2032 (USD Million)
TABLE 332. BRICS Artificial Organs Market Size, by Bioartificial Kidney, 2017-2032 (USD Million)
TABLE 333. BRICS Artificial Organs Market Size, by Bioartificial Liver, 2017-2032 (USD Million)
TABLE 334. BRICS Artificial Organs Market Size, by Mechanical, 2017-2032 (USD Million)
TABLE 335. BRICS Artificial Organs Market Size, by Dialysis Machine, 2017-2032 (USD Million)
TABLE 336. BRICS Artificial Organs Market Size, by Extracorporeal Membrane Oxygenation, 2017-2032 (USD Million)
TABLE 337. BRICS Artificial Organs Market Size, by Ventricular Assist Device, 2017-2032 (USD Million)
TABLE 338. BRICS Artificial Organs Market Size, by Tissue Engineered, 2017-2032 (USD Million)
TABLE 339. BRICS Artificial Organs Market Size, by Cell-Based Therapies, 2017-2032 (USD Million)
TABLE 340. BRICS Artificial Organs Market Size, by Scaffold-Based Constructs, 2017-2032 (USD Million)
TABLE 341. BRICS Artificial Organs Market Size, by Technology, 2017-2032 (USD Million)
TABLE 342. BRICS Artificial Organs Market Size, by 3D Bioprinting, 2017-2032 (USD Million)
TABLE 343. BRICS Artificial Organs Market Size, by End User, 2017-2032 (USD Million)
TABLE 344. BRICS Artificial Organs Market Size, by Ambulatory Care Centers, 2017-2032 (USD Million)
TABLE 345. BRICS Artificial Organs Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 346. BRICS Artificial Organs Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 347. G7 Artificial Organs Market Size, by Group, 2017-2032 (USD Million)
TABLE 348. G7 Artificial Organs Market Size, by Organ Type, 2017-2032 (USD Million)
TABLE 349. G7 Artificial Organs Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 350. G7 Artificial Organs Market Size, by Bioartificial, 2017-2032 (USD Million)
TABLE 351. G7 Artificial Organs Market Size, by Bioartificial Kidney, 2017-2032 (USD Million)
TABLE 352. G7 Artificial Organs Market Size, by Bioartificial Liver, 2017-2032 (USD Million)
TABLE 353. G7 Artificial Organs Market Size, by Mechanical, 2017-2032 (USD Million)
TABLE 354. G7 Artificial Organs Market Size, by Dialysis Machine, 2017-2032 (USD Million)
TABLE 355. G7 Artificial Organs Market Size, by Extracorporeal Membrane Oxygenation, 2017-2032 (USD Million)
TABLE 356. G7 Artificial Organs Market Size, by Ventricular Assist Device, 2017-2032 (USD Million)
TABLE 357. G7 Artificial Organs Market Size, by Tissue Engineered, 2017-2032 (USD Million)
TABLE 358. G7 Artificial Organs Market Size, by Cell-Based Therapies, 2017-2032 (USD Million)
TABLE 359. G7 Artificial Organs Market Size, by Scaffold-Based Constructs, 2017-2032 (USD Million)
TABLE 360. G7 Artificial Organs Market Size, by Technology, 2017-2032 (USD Million)
TABLE 361. G7 Artificial Organs Market Size, by 3D Bioprinting,

Companies Mentioned

  • Alt-Bionics, LLC
  • Axiles Bionics
  • Baxter International Inc.
  • Berlin Heart GmbH
  • Beta Bionics, Inc.
  • Bionic India
  • Boston Scientific Corporation
  • Carmat SA
  • COVVI Ltd.
  • Ekso Bionics Holdings, Inc.
  • German Bionic Systems GmbH
  • iWALKFree, Inc.
  • Jarvik Heart, Inc.
  • Medtronic Plc
  • Nipro Corporation
  • Open Bionics Ltd.
  • Pixium Vision SA
  • ReWalk Robotics Ltd.
  • Sonova AG
  • SynCardia Systems, LLC
  • Vivani Medical, Inc.
  • Zimmer Biomet Holdings, Inc.
  • Össur hf.

Related Topics

Related Reports

Artificial Organ Bank Market - Global Forecast 2026-2032 - Product Image

Artificial Organ Bank Market - Global Forecast 2026-2032

  • Report
  • 196 Pages
  • Global
From
Artificial Organ & Bionics Market - Global Forecast 2026-2032 - Product Image

Artificial Organ & Bionics Market - Global Forecast 2026-2032

  • Report
  • 188 Pages
  • Global
From
Artificial Organs Market Size, Share, Trends and Forecast by Type and Region 2026-2034 - Product Image

Artificial Organs Market Size, Share, Trends and Forecast by Type and Region 2026-2034

  • Report
  • 148 Pages
  • Global
From
Artificial Organs and Bionics - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031) - Product Image

Artificial Organs and Bionics - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

  • Report
  • 130 Pages
  • Global
From
Artificial Organs - Global Strategic Business Report - Product Image

Artificial Organs - Global Strategic Business Report

  • Report
  • 164 Pages
  • Global
From

About the Artificial Organ Market

The Artificial Organ market is a subset of the Biomaterials industry, which focuses on the development of materials for use in medical applications. Artificial organs are designed to replace or supplement the function of a damaged or missing organ, and can be made from a variety of materials, including polymers, metals, and ceramics. These materials are chosen for their biocompatibility, durability, and ability to interact with the body's natural systems. The Artificial Organ market is driven by advances in medical technology, as well as the increasing prevalence of chronic diseases and organ failure. The market is expected to grow in the coming years, as more people seek out treatments for their conditions. Companies in the Artificial Organ market include Abiomed, SynCardia Systems, and WorldHeart Corporation. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.